Needham Investment Management LLC decreased its position in shares of Mativ Holdings, Inc. (NYSE:MATV - Free Report) by 8.3% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 442,500 shares of the company's stock after selling 40,000 shares during the period. Needham Investment Management LLC owned 0.81% of Mativ worth $4,823,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of MATV. Federated Hermes Inc. acquired a new stake in Mativ during the 4th quarter valued at $33,000. KBC Group NV lifted its position in Mativ by 93.2% in the 4th quarter. KBC Group NV now owns 4,787 shares of the company's stock valued at $52,000 after purchasing an additional 2,309 shares during the last quarter. Quantbot Technologies LP bought a new stake in Mativ in the 4th quarter valued at about $122,000. AlphaQuest LLC raised its position in shares of Mativ by 20,544.8% during the 4th quarter. AlphaQuest LLC now owns 11,974 shares of the company's stock worth $131,000 after buying an additional 11,916 shares in the last quarter. Finally, Oxford Asset Management LLP bought a new stake in shares of Mativ during the 4th quarter worth about $133,000. Hedge funds and other institutional investors own 94.95% of the company's stock.
Mativ Trading Up 1.3%
Shares of MATV stock traded up $0.08 during trading hours on Friday, reaching $6.06. 464,263 shares of the stock traded hands, compared to its average volume of 592,463. Mativ Holdings, Inc. has a 1-year low of $4.34 and a 1-year high of $19.96. The business has a fifty day moving average price of $5.52 and a 200 day moving average price of $8.92. The company has a quick ratio of 1.29, a current ratio of 2.40 and a debt-to-equity ratio of 1.28. The firm has a market capitalization of $330.11 million, a PE ratio of -6.73, a PEG ratio of 1.08 and a beta of 0.61.
Mativ (NYSE:MATV - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.03). The business had revenue of $484.80 million during the quarter, compared to the consensus estimate of $470.30 million. Mativ had a positive return on equity of 3.86% and a negative net margin of 2.46%. On average, equities research analysts forecast that Mativ Holdings, Inc. will post 1.15 EPS for the current year.
Mativ Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, June 27th. Investors of record on Friday, May 23rd will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a dividend yield of 6.61%. The ex-dividend date of this dividend is Friday, May 23rd. Mativ's dividend payout ratio (DPR) is currently -4.88%.
Wall Street Analyst Weigh In
Separately, Stifel Nicolaus upgraded shares of Mativ from a "hold" rating to a "buy" rating and dropped their price target for the stock from $15.50 to $10.00 in a research report on Monday, March 24th.
View Our Latest Analysis on MATV
Mativ Company Profile
(
Free Report)
Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.
Read More

Before you consider Mativ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mativ wasn't on the list.
While Mativ currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.